Raffles Medical Group Ltd

Equities

BSL

SG1CH4000003

Healthcare Facilities & Services

Delayed Singapore S.E. Other stock markets 09:29:55 04/07/2024 am IST			5-day change	1st Jan Change
1.02 ^SGD	0.00%		+3.55%	-5.56%

29/05	Raffles Medical Group’s Director Acquires Additional Shares	MT
26/04	Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	CI

Change - Announcement of Appointment::Appointment of Non-Executive and Independent Director as Member of Audit & Risk Committee

December 01, 2021 at 05:31 pm IST

Appendix 1

Mr Tan Wern Yuen

Other Principal Commitments Including Directorships for the Last 5 YearsAs At : 1 December 2021(Date)

No.	Name of Company

Board Observer, JD.com
Board Director, Dada Nexus
CEO China, Walmart Inc.
Managing Director Taiwan, McDonald's Corporation

Attachments

Original Link
Original Document
Permalink

Disclaimer

Raffles Medical Group Ltd. published this content on 01 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2021 12:00:05 UTC.

Latest news about Raffles Medical Group Ltd

Raffles Medical Group’s Director Acquires Additional Shares	29/05	MT
Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	26/04	CI
Raffles Medical Group Ltd Announces Changes in Composition of the Board of Directors and Board Committees	22/04	CI
Raffles Medical Group Ltd Appoints Lim Sim Seng as Member of the Audit & Risk Committee, Effective 23 April 2024	22/04	CI
Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	03/04	CI
Raffles Medical Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	03/04	CI
CGS-CIMB Research Adjusts Raffles Medical Group’s Price Target to SG$1.16 From SG$1.20, Keeps at Buy	29/02	MT
PhillipCapital Adjusts Raffles Medical Group’s Price Target to SG$0.96 From SG$1.02, Keeps at Neutral	29/02	MT
Maybank Securities Adjusts Raffles Medical Group’s Price Target to SG$1.15 From SG$1.30, Keeps at Hold	29/02	MT
Raffles Medical’s Attributable Profit in H2 2023 Plunges 64%; Shares Down 4%	26/02	MT
Raffles Medical Buys Back Shares	12/12	MT
Raffles Medical Buys Back Shares	08/12	MT
Raffles Medical Buys Back Shares	07/12	MT
Explainer-What do we know about China's respiratory illness surge?	01/12	RE
Raffles Medical Buys Back Shares	24/11	MT
Raffles Medical Group Repurchases Shares	21/11	MT
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.20 From SG$1.77, Keeps at Add	09/11	MT
DBS Group Research Adjusts Raffles Medical Group's Price Target to SG$1.00 From SG$1.48, Keeps at Hold	09/11	MT
Maybank Securities Downgrades Raffles Medical Group to Hold From Buy, Adjusts Price Target to SG$1.30 From SG$1.65	09/11	MT
RHB Bank Singapore Downgrades Raffles Medical Group to Neutral From Buy, Adjusts Price Target to SG$1.15 From SG$1.75	09/11	MT
PhillipCapital Research Downgrades Raffles Medical Group to Neutral From Buy, Adjusts Price Target to SG$1.02 From SG$1.76	09/11	MT
Raffles Medical Buys Back Shares	08/11	MT
Nomura Adjusts Raffles Medical’s Price Target to SG$1.40 From SG$1.60, Keeps at Buy	07/11	MT
Raffles Medical Group Ltd commences an Equity Buyback Plan for 186,006,062 shares, representing 10% of its issued share capital, under the authorization approved on April 28, 2023.	07/11	CI
Singapore Index Soars Over 1%; DBS Group Shares Climb 1% on Posting 18% Increase in Q3 Net Profit	06/11	MT

Chart Raffles Medical Group Ltd

Duration

Period

More charts

Company Profile

Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. The principal activities of the Company are those relating to the operation of medical clinics, other general medical services, and investment holdings. The Companyâs segments include Healthcare Services, Hospital Services, and Investment Holdings. The Healthcare Services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital Services segment is engaged in the provision of specialized medical services and operation of hospital and business of medical laboratory and imaging center. The Investment Holdings segment is engaged in investment holding and those relating to investment properties. It operates medical facilities in about 14 cities in Singapore, China, Japan, Vietnam, and Cambodia.

Sector

Healthcare Facilities & Services

Calendar

29/07/2024 - Q2 2024 Earnings Release

More about the company